Contact Us

Get 30% Free Customization on This Report

Published Date: May, 2019

Cancer Therapeutics and Supportive Care Drugs Market (Drug Class - ESAS, Bisphosphonates, Opioids, G-CSFS, Antiemetics, NSAIDs, and Other Drug Classes; Distribution Channel - Hospital, and Retail): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on cancer therapeutics and supportive care drugs market provides in-depth analysis of segments and sub-segments in the global as well as regional cancer therapeutics and supportive care drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cancer therapeutics and supportive care drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cancer therapeutics and supportive care drugs market. According to the report, the global cancer therapeutics and supportive care drugs market is projected to grow at a CAGR of 9.4 % over the forecast period of 2019-2025.


Market Insight

Cancer is an abnormal growth of cells and it is also known as malignancy. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery. New trends in oncology drug development are reflected in the increasing use of biotechnology in the development of anticancer drugs, including immunotherapies or monoclonal antibodies, adoptive-cell therapies, and new vaccines.


New treatment options have become available in the past five years, and the surge of innovation is expected to continue due to a robust pipeline of drugs in clinical development by a large and diverse group of pharmaceutical companies. Innovations in the development of new drugs and therapies, a large number of new drugs entering into the market with FDA approval, increasing prevalence of cancerous patients, availability of new treatment options in the market and rise in base of aging the population is the key driving factors for the growth of this market. In addition, changing lifestyle habits of populations increased patient’s healthcare awareness and increasing demand for non-invasive therapies are further expected to propel the market growth in the coming years. Along with these driving factors, the market for cancer therapeutics is facing some challenges such as time-consuming regulatory compliance and the high cost of cancer drugs. However, the market for cancer therapeutics and supportive care drugs is likely to rise in the future due to a large number of ongoing innovations for the treatment of cancer.


Geographically, North America is the leading contributor to the market and it is expected to retain its position during the forecast period due to high awareness, the presence of a large base of cancer patients, rise in investments, and various initiatives by government in the healthcare sector. However, the Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments and growing awareness among the population about the treatment options available in the market.

Global Cancer Therapeutics and Supportive Care Drugs Market


Segment Covered

The report on global cancer therapeutics and supportive care drugs market covers segments such as drug class and distribution channel. On the basis of drug class, the sub-markets include ESAS, bisphosphonates, opioids, G-CSFS, antiemetics, NSAIDs, and other drug classes. On the basis of distribution channel, the sub-markets include hospital and retail.


Companies Profiled:

The report provides profiles of the companies in the market such as Takeda Pharmaceutical Company LtdTeva Pharmaceutical Industries Ltd., AbbVie Inc., Sanofi S.A, Eli Lilly and Company, Novartis International AG, Pfizer Inc, Johnson & Johnson, Bristol-Myers Squibb Company, Astellas Pharma Inc, and Other companies.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cancer therapeutics and supportive care drugs market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter